Amgen Inc.
Synthesis of (S)-2-Amino-4-Methyl-((R)-2-Methyloxirane-2-Yl)-Pentan-1-One and Pharmaceutically Acceptable Salts Thereof

Last updated:

Abstract:

The present invention provides new methods for preparing compound 5, and pharmaceutically acceptable salts thereof, of structure ##STR00001## Compound 5, or a pharmaceutically acceptable salt thereof, is an important intermediate in the synthesis of carfilzomib. The invention further provides methods of making a useful manganese catalyst that may be used in the epoxidation step of the present invention.

Status:
Application
Type:

Utility

Filling date:

3 Aug 2017

Issue date:

16 Sep 2021